New Paper Highlights Antimicrobial Effectiveness Of Medical-Grade Honey In Topical Wound Care : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

New Paper Highlights Antimicrobial Effectiveness Of Medical-Grade Honey In Topical Wound Care

July 22, 2009

Princeton, NJ (RPRN) 7/22/2009 -- According to a recent paper published in the European Journal of Clinical Microbiological Infectious Diseases, a certain kind of honey can be an effective agent in topical wound care, particularly where antibiotic resistance is an issue. The irony is that this most exciting new treatment has been around since the dawn of history—honey was first used as a first aid treatment four thousand years ago in Ancient Egypt.

Entitled, “The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis,” the report describes the palliative effects of Leptospermum honey, a particular kind of honey indigenous to New Zealand and Australia. Leptospermum honey has been shown to possess unique plant derived components that make it an ideal wound dressing, including novel antimicrobial and immune-modulatory compounds. In addition, the honey has several properties that also aid in wound healing. Among these properties are the honey’s low pH levels, its ability to help remove non-vital tissue from the wound area, the stimulation of new tissue growth, and reported reduction in scarring and pain levels. What is also key is that all these benefits exist without any toxicity to healthy tissue. “There is an urgent need for new, effective agents in topical wound care,” the report begins, “and selected honeys show potential in this regard.”

The paper also describes how medical-grade honey might be a strong combatant against antibiotic resistant pathogens such as MRSA and vancomycin-resistant strains (VRS). “Staphylococcus aureus is one of the most commonly acquired pathogens in both the community and the hospital settings, and it is particularly problematic in skin and wound infections. The emergence of methicillin resistant S. aureus (MRSA), and, more recently, vancomycin-resistant strains, has seriously compromised treatment options,” the report states. “Multi-drug resistance limits treatment options and results in the use of more expensive or more toxic drugs, with corresponding increases in patient morbidity and mortality. . . The current issues surrounding antibiotic resistance, and a growing body of evidence supporting the use of honey as a dressing for a wide range of wounds, has increased interest in its use in the clinic.”

MEDIHONEY dressings, a unique line of products containing active Leptospermum honey, provide a moist, occlusive environment conducive to optimal wound healing and contain a high percentage of honey, enabling them to work effectively in the presence of wound fluid, blood, and tissue, promoting an optimal healing environment. Available in dressings and gel form, MEDIHONEY products, leading brand of Princeton, New Jersey-based Derma Sciences Inc., are indicated for the management of lightly to heavily exuding wounds such as: Diabetic foot ulcers, venous stasis leg ulcers, arterial leg ulcers, leg ulcers of mixed etiology, pressure ulcers (I-IV), first and second degree burns, donor sites, traumatic and surgical wounds.

“The paper also shows that MEDIHONEY is effective against antibiotic resistant strains,” says Edward J. Quilty, Chairman and Chief Executive Officer of Derma Sciences Inc. “Although this has been demonstrated before, this article does a great job of showing that not only is it effective against these strains, but that the same amount of MEDIHONEY is necessary for the non-resistant strains as is required for the resistant strains. This is unusual, as more antibiotic or antimicrobial is typically necessary for the antibiotic resistant strains.”

The paper also demonstrates that use of MEDIHONEY at sub-lethal levels (levels too low to kill bacteria) does not induce resistance. This is unusual because this is precisely what causes resistant strains to form after sub-lethal antibiotic / antimicrobial concentration exposure. Further, a gene expression analysis was undertaken to see if MEDIHONEY’s effect was different than that of traditional antibiotics.  The conclusion was “when compared to the published data on the effects of various antibiotics on the gene expression of E. coli, active Leptospermum honey produced a unique expression signature, suggesting that it works by a different mode of action to the other inhibitors.”

“The data presented here argue for a greater use of medicinal-grade honey in wound care, particularly where antibiotic resistance is an issue,” the European Journal of Clinical Microbiological Infectious Diseases paper concludes. “Our study suggests that it is unlikely that resistance to honey will develop, even with increased use. . . The gene expression signature of E. coli cells exposed to active Leptospermum honey indicates that it has a mode of action that is distinct from conventional antibiotics. Further investigations into the mode of action of the non-peroxide antibacterial activity of this honey are warranted, as these may lead to new classes of antimicrobials, which are desperately needed.”

Derma Sciences has a partnership with Comvita, a company located in New Zealand, which controls 75% of the Leptospermum honey harvested and has strong IP around dressing configurations that include honey. Derma Sciences currently has exclusive rights for MEDIHONEY in the Americas. For more information, please visit http://www.dermasciences.com.

Media contact:

Susan Morgenbesser

The Investor Relations Group

212-825-3210

Photo credit: Fotolia

About the author:

Janet Vasquez, Director of Corporate Communications

About IRG

We are The Investor Relations Group (IRG), a full-service corporate communications firm that provides investor relations and public relations services to nano-, micro- and small-cap companies providing them with the equivalent in-house services of a large-cap company.

http://www.investorrelationsgroup.com

Click here to see all news from this author/company

Filed Under: Health and Fitness, CONSUMER GOODS, Lifestyle, PRESS RELEASE, GOOGLE NEWS, FDA- Pharmaceutical news

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Coffee With Dr. Stewart

Austin, TX 11/25/14 · A brother and sister bring an exciting new...

Arki Kickstarter reaches $100K target in 13 days

Los Angeles/Seoul, Korea 11/24/14 · One step closer to a walking revolution The kickstarter...

Zikto taking award-winning Arki to Startup Nations Summit

Seoul, Korea 11/22/14 · Zikto taking award-winning Arki to Startup Nations Summit The...

The End of Transparency? Don't be a fraud target

Carrollton, TX 11/18/14 · - Over the years, progressive and productive societies...

Ultraseal international in finals of Midlands Business Awards 2015

Coventry, UK 11/14/14 · Ultraseal International, which exports to the automotive supply...

Arki: Hot New Wearable Tech Setting a Cracking Pace on Kickstarter

San Francisco, CA 11/14/14 · Update for November 21: 412 Backers $90,034 pledged...

UpWest Labs Unveils Details of Its Eighth Batch of Startups, Ranging From Genetics to 3D Design

Palo Alto, California 11/11/14 · Accelerator continues to support innovative entrepreneurs with its...

Modern Casting Impregnation helps automakers to avoid warranty claims on engines

Novi, MI 11/11/14 · Automakers can save money and avoid costly warranty...

The Evolution of Walking: Wearable Tech steps up to a new level

San Francisco, CA 11/11/14 · Arki: Finally Wearable Meets Fashion – Wearable technology is one of 2014’s...

GeneSegues Awarded $1 Million Phase II NIH/NCI Research Contract for Nanoencapsulated RNAi Cancer Therapeutic

MINNEAPOLIS, MN 11/10/14 · Highly Competitive NIH Program Validates Potential of GS-10...

More Than 400 .Onion Addresses Targeted as Part of Global Enforcement Action on Tor Network

WASHINGTON 11/07/14 · More Than 400 .Onion Addresses, Including Dozens of...

Learn about Wine in Your Pjs - A New Kind of Wine Class

SAUSALITO, CA. 11/04/14 · The Wine Key announced today it's first virtual...

XCEL Professional Services Has Made a Huge Change to Move Our Company Forward

Calgary, AB 11/04/14 · Introducing Rob Hay: The New President of XCEL...